Aljure O, Díez-Sampedro A. Functional characterization of mouse sodium/glucose transporter type 3b. Am J Physiol Cell Physiol 299: C58 -C65, 2010. First published April 14, 2010 doi:10.1152/ajpcell.00030.2010.-Despite belonging to a family of sugar cotransporters, human sodium/glucose transporter type 3 (hSGLT3) does not transport sugar, but it depolarizes the cell in the presence of extracellular sugar, and thus it has been suggested to work as a sugar sensor. In the human genome there is one SGLT3 gene, yet in mouse there are two. In this study we cloned one of them, mouse SGLT3b (mSGLT3b) and characterized the protein. We found that mSGLT3b has low affinity for sugars, as does hSGLT3, but surprisingly, mSGLT3b transports sugar, although the sugar transport is not as tightly coupled to cations as in SGLT1. Moreover, the sugar specificity of mSGLT3b has characteristics reminiscent of both SGLT1 and hSGLT3: mSGLT3b does not respond to galactose, similar to hSGLT3, but neither does it respond to 1-deoxynojirimycin, unlike hSGLT3 but similar to SGLT1. mSGLT3b has low apparent affinities for sugar and Na ϩ and, furthermore, displays pre-steady-state currents, which in SGLT1 report on conformational changes in the protein. Finally, phlorizin, the typical inhibitor of SGLT proteins, also inhibits mSGLT3b. In summary, although mSGLT3b has some characteristics that resemble SGLT1 and others that are similar to hSGLT3, its low sugar affinity and uncoupled sugar transport lead us to conclude that mSGLT3b likely functions as a physiological glucose sensor similar to hSGLT3. sugar transport; sugar sensor; sodium-sugar cotransporter TWO DIFFERENT FAMILIES of proteins are responsible for sugar transport in cells, the glucose transporter (GLUT) family and the sodium/glucose transporter (SGLT) family (25, 28) . GLUT proteins [SLC2 gene family (22)] are facilitator transporters that move sugar down its concentration gradient without any energy expenditure. In contrast, SGLT proteins [SLC5 gene family (26)] are secondary active transporters and concentrate sugar inside of cells using the energy from the Na ϩ electrochemical gradient. In pancreatic ␤-cells the GLUT2 transporters, along with ATP-sensitive potassium (K ATP ) channel, form part of a metabolic glucose sensing system that can trigger insulin release upon glucose metabolism and generation of ATP (2).
TWO DIFFERENT FAMILIES of proteins are responsible for sugar transport in cells, the glucose transporter (GLUT) family and the sodium/glucose transporter (SGLT) family (25, 28) . GLUT proteins [SLC2 gene family (22) ] are facilitator transporters that move sugar down its concentration gradient without any energy expenditure. In contrast, SGLT proteins [SLC5 gene family (26) ] are secondary active transporters and concentrate sugar inside of cells using the energy from the Na ϩ electrochemical gradient. In pancreatic ␤-cells the GLUT2 transporters, along with ATP-sensitive potassium (K ATP ) channel, form part of a metabolic glucose sensing system that can trigger insulin release upon glucose metabolism and generation of ATP (2) .
The primary function of two well-characterized members of the SGLT family, SGLT1 and SGLT2, is to transport glucose across epithelia. SGLT1 has high affinity for sugar [0.1-0.5 mM (4, 10, 12) ] while SGLT2's affinity for sugar is lower [ϳ3 mM (27) ]. Interestingly, human SGLT3 (hSGLT3) was recently characterized and functions differently than these sugar transporters. When heterologously expressed, hSGLT3 does not transport any glucose, but instead depolarizes the cell when activated by sugar (6) . The fact that sugar depolarizes the cell indicates that the protein likely functions as a sugar sensor in tissues where it is expressed. This novel glucose sensing system can work independently of the metabolic GLUT-K ATP system.
Unlike humans, mouse and rat genomes have two different genes coding for SGLT3, SGLT3a and SGLT3b. Mouse chromosome 10 contains the genes coding for both of these proteins (20) whose molecular characteristics and functions have not been established. Since the first publication of the function of human SGLT3, several physiological studies on glucose sensing in rodents have either suggested or excluded involvement of SGLT3 (a or b), but without knowing their molecular functions (9, 15) . In this study we cloned SGLT3b from mouse kidney (mSGLT3b) and characterized its activity to understand the molecular features and to determine whether it serves as an appropriate model system for hSGLT3 and its role in physiology.
By measuring and analyzing sugar transport, apparent sugar and sodium affinities and pre-steady-state currents, we found that mSGLT3b has characteristics that are similar to either SGLT1 or hSGLT3. However, despite measurable sugar transport, its low sugar apparent affinity and uncoupled cation/sugar transport suggest that mSGLT3b likely functions as a sugar sensor similar to hSGLT3.
METHODS
Cloning of mouse SGLT3b. Full-length mouse SGLT3b cDNA was generated from 0.25 g of mouse kidney polyA-RNA (Ambion) using oligo(dT) primers and Superscript III Reverse Transcriptase (Invitrogen). PCR was carried out with the following primers: sense 5=-GGA AAG GAC CAG AAC CTC CT-3= (from Ϫ24 bp to Ϫ7 bp relative to adenine of start codon) and antisense 5=-CAG GGT TCA GGC AAA ATA GG-3= (inverse of stop codon is underlined) using Platinum Taq DNA Polymerase High Fidelity (Invitrogen). The PCR product was cloned into the pCR2.1-TOPO vector using the TOPO-TA cloning kit (Invitrogen). Mouse SGLT3b was then subcloned into the vector pGH19 for in vitro transcription and expression in oocytes.
Expression of proteins in Xenopus laevis oocytes. cDNA for mSGLT1 is inserted in a pCMV-Sport 6 vector (4) and cDNA for mSGLT3b is in the vector pGH19. The cDNA was linearized with XhoI, and RNA was transcribed and capped in vitro using the T7 RNA promoter (MEGAscript kit, Ambion). Mature Xenopus laevis oocytes were injected with 50 ng of RNA coding for each protein. Oocytes were maintained in OR2 solution supplemented with penicillin (10,000 U/ml) and streptomycin (10 mg/ml) at 19°C for 4 -8 days until used.
Electrophysiology. Experiments were performed using the twoelectrode voltage-clamp method (OC-725C, Warner Instruments) in a rapid perfusion chamber at 21-22°C. During experiments, the oocytes were bathed in Na ϩ solution composed of (in mM) 100 NaCl, 2 KCl, 1 MgCl 2, 1 CaCl2, and 10 HEPES-Tris, pH 7.4, and in the Na ϩ -free buffer, choline-Cl replaced NaCl. The membrane potential was held at Ϫ50 mV and stepped for 100 ms from ϩ50 mV to Ϫ150 mV in 20-mV decrements. The sugar-dependent current was defined as the difference between the current recorded with and without sugar. The experiments were controlled and data were acquired using pClamp software (Axon Instruments) and a digital interface (Digidata 1440, Axon Instruments).
The apparent Na ϩ affinity (K Na 0.5) was determined using increasing Na ϩ concentrations (0 to 100 mM) in 150 mM ␣-methyl-Dglucose (␣M-glc). The apparent sugar affinity (K0.5) was obtained in 100 mM Na ϩ with increasing sugar concentrations (0 to 150 mM). The steady-state currents at each membrane potential were fit to Eq. 1:
where I max is the maximal current, [S] is the substrate concentration, K0.5 is the substrate concentration at one-half Imax, and n is the Hill coefficient. For fitting of sugar or phlorizin dose-response curves, n was set to 1.
Pre-steady-state currents. Pre-steady-state transient currents were recorded when returning the voltage from various test potentials to Ϫ50 mV. Currents were fit with double exponentials, and the membrane capacitive component obtained from the fit was then subtracted from the current record, leaving the "Off" currents attributable to the transporter. The pre-steady-state transient charge, Q, was determined by integration of this transient Off current with time, and the distribution of the charge moved as a function of membrane voltage (V) was obtained by fitting the data with a Boltzmann equation of the form
where Q max ϭ Qdep Ϫ Qhyp (Qdep and Qhyp are Q at depolarizing and hyperpolarizing limits, respectively), F is the Faraday constant, R is the gas constant, T is the absolute temperature, V 0.5 is the membrane potential where there is 50% charge transfer, and z is apparent valence of the movable charge. Fits of data with equations were performed using SigmaPlot 9.0 (SPSS).
Sugar uptake experiments. The oocytes were incubated in 50 M ␣M-glc with radiolabeled traces of 14 C-␣M-glc. To study the effect of phlorizin on the sugar uptake, phlorizin was added to the incubation media. After the incubation, the oocytes were washed with cold Na ϩ -free solution and individually solubilized, and sugar uptake was determined by using a scintillation counter. Sugar uptake in noninjected oocytes from the same batch of oocytes was used as control. For stoichiometry experiments, individual oocytes were clamped at Ϫ90 mV and incubated with 5 mM ␣M-glc and traces of 14 C-␣M-glc while simultaneously recording the sugar-induced current. After the incubation time, each oocyte was solubilized and sugar uptake was determined. The uptake in oocytes without injected cRNA was subtracted. The induced current was converted to its molar equivalent as previously described (5) .
RESULTS

Cloning of mSGLT3b.
We cloned full-length mouse mSGLT3b cDNA from mouse kidney polyA-RNA. The sequence of our full-length cDNA clone was identical to that previously published, which was assembled as the consensus sequence from multiple partial clones [ (21) ; NM_023219].
Sugar selectivity. Despite 70% amino acid identity between human SGLT3 and human SGLT1, they present different selectivity for sugars that activate them (23) . mSGLT3b has 76% amino acid identity with human SGLT3 and 72% with mouse SGLT1. To determine the sugar selectivity of mSGLT3b, we measured sugar-induced depolarizations (Fig. 1A) in oocytes expressing the protein after RNA injection. 50 mM glucose, ␣M-glc, 1-deoxy-glucose (1DO-glc), and 6DO-glc induced depolarizations of approximately 30, 40, 10, and 50 mV, respectively, indicating that each of these sugars bound to and activated mSGLT3b. In contrast, neither 2DO-glc, 3-O-methyl-glucose (3OM-glc), 3DO-glc, nor galactose induced changes in membrane potential at the same concentration. We also tested the imino sugars 1-deoxy-nojirimycin (DNJ) and 1-deoxy-galactonojirimycin (DGN) at 500 M and found that they, too, had no effect. DNJ was tested on mSGLT3b (n ϭ 7) and the same solutions activated hSGLT3 (data not shown). Notably, while galactose does not interact with hSGLT3, as we found with mSGLT3b, imino sugars like DNJ bind with high affinity to hSGLT3 (K 0.5 is ϳ4 M) and induce depolarizations larger than glucose [ϳ2.5-fold larger (23)]. These results indicate that mSGLT3b has sugar selectivity distinct from its human homolog, hSGLT3, but also from SGLT1. Some of these sugars were also tested by measuring their induced currents at different voltages. Figure 1B shows the current induced by 150 mM ␣M-glc, glucose, and galactose, and 500 M DNJ at voltages ranging from ϩ50 mV to Ϫ150 mV. As expected from the depolarization experiment, we found that galactose and DNJ did not induce current.
Low affinity for sugars and Na ϩ . After having determined which sugars interacted with mSGLT3b ( Fig. 1, A and B) , we then determined the apparent affinity of the sugars that induced Fig. 1 . Mouse sodium/glucose transporter type 3 (mSGLT3b) is activated by sugars. A: sugar-induced depolarizations in one mSGLT3b-expressing oocyte. The sugars tested were 50 mM glucose (glc), ␣-methyl-D-glucose (␣M-glc), 1-deoxy-glucose (1DO-glc), 2DO-glc, 3-O-methyl-glucose (3OM-glc), 3DO-glc, galactose (Gal), and 6DO-glc, along with 500 M of the imino sugars 1-deoxy-nojirimycin (DNJ) and 1-deoxy-galactonojirimycin (DGN). The sugars that induced the highest depolarizations were glucose, ␣M-glc, and 6DO-glc. B: sugar-induced currents (I) from a representative oocyte expressing mSGLT3b at voltages between ϩ50 mV and Ϫ150 mV. In B, the concentrations of sugars were 150 mM for all but DNJ, which was tested at 500 M.
the largest depolarizations by determining a dose-response curve to each of those sugars: glucose, ␣M-glc, and 6DO-glc. Figure 2A shows a typical example of glucose-induced currents measured in one mSGLT3b-expressing oocyte at voltages ranging from Ϫ150 mV to ϩ50 mV and at concentrations ranging from 5 mM to 150 mM. The currents were larger at higher glucose concentrations. The sugar-induced currents at each voltage were plotted as a function of the sugar concentration and the data were fit with Eq. 1 (see METHODS) to obtain the apparent sugar affinity (K 0.5 ) and the maximal sugarinduced current (I max ). Figure 2B shows an example from a single oocyte of fits (dotted lines) for glucose and 6DO-glc at Ϫ150 mV by which we obtained a K 0.5 for glucose of 65 mM, while 6DO-glc presented a lower K 0.5 , 17 mM. Apparent sugar affinities determined from different mSGLT3b-expressing oocytes at voltages from Ϫ150 mV to Ϫ30 mV were averaged and are shown for glucose (n ϭ 3) and 6DO-glc (n ϭ 2) in Fig.  2C . Across a wide range of voltages we found that the apparent affinity of 6DO-glc for mSGLT3b was approximately fourfold stronger than glucose. Apparent ␣M-glc affinities at the same voltages were also determined, and the K 0.5 values were similar to glucose (Supplemental Fig. 1 ; supplemental data for this article can be found online at American Journal of Physiology-Cell Physiology website). 1DO-glc displayed a significant depolarization when tested at 50 mM in mSGLT3b-expressing oocytes (Fig. 1A) . However, when we attempted to determine the apparent affinity, we obtained a very weak K 0.5 , higher than 150 mM (not shown), indicating that the lack of ϪOH at the first position of the sugar significantly reduces the interaction with or activation of the protein. Figure 2D shows the average of the maximal currents (I max ) obtained with glucose and 6DO-glc at voltages between Ϫ150 mV and Ϫ10 mV. Although the currents induced by glucose were larger, these values will depend on the protein expression levels in different batches of oocytes, and thus this difference between glucose and 6DO-glc in I max may not be meaningful.
We next determined the apparent Na ϩ affinity of mSGLT3b. Sugar-induced currents (150 mM ␣M-glc) were measured in different Na ϩ concentrations (from 0 to 100 mM) at voltages ranging from Ϫ150 mV to Ϫ10 mV. Figure 3A shows typical currents obtained from a single oocyte at Ϫ90 mV at different Na ϩ concentrations, and fit (dashed line) with Eq. 1 to estimate the apparent Na ϩ affinity (K Na 0.5 ϳ23 mM). Figure 3B shows averaged K Na 0.5 from four oocytes across a range of voltages. The Hill coefficient, n, was also obtained at each voltage, and it ranged from 1.1 to 1.5.
Transport of sugar. SGLT1 and SGLT2 are Na ϩ -glucose cotransporters (25) . Human SGLT3 shows no sugar transport when expressed in oocytes, yet depolarizes the membrane when sugar is present (6) . Our results show that sugar depolarizes oocytes expressing mSGLT3b. To determine whether mSGLT3b transports sugar, we performed sugar uptake experiments in oocytes expressing mSGLT3b by using 50 M ␣M-glc with traces of 14 C-␣M-glc. We found that ␣M-glc uptake was significantly higher in mSGLT3b-expressing oocytes than in noninjected control oocytes (7.5 Ϯ 0.5 pmol/h vs. 2.0 Ϯ 0.2 pmol/h, P ϭ 0.0007 by t-test; n ϭ 3), yet was about 60 times lower than uptake in mouse SGLT1-expressing oocytes (448 Ϯ 57 pmol/h; n ϭ 3) (Fig. 4A) . The data below will further suggest that weak apparent affinity for sugar is the primary determinant of decreased sugar transport in mSGLT3b. To know whether this sugar transport was coupled to cation transport, we determined the stoichiometry of mSGLT3b by simultaneously measuring the sugar uptake and the net charge movement into the oocyte. In this experiment, the oocyte was clamped at Ϫ90 mV and perfused with 5 mM ␣M-glc. In each oocyte the radiolabeled sugar uptake was counted and the sugar-induced current was determined. In Fig. 4B , each point corresponds with one individual oocyte. A linear regression was fit to the data, and the slope indicated that ϳ2.6 charges were transported with each sugar molecule (mean Ϯ SE of individual oocytes is 2.60 Ϯ 0.09). This result can be compared with the very tight stoichiometry of 2:1 obtained in hSGLT1 (14) .
Phlorizin inhibition of mSGLT3b. Phlorizin (Pz), a phenolicglucoside first isolated from apple tree bark in 1835 (8) 
To determine whether Pz also blocks sugar uptake and sugar-induced current in mSGLT3b, we added Pz to the bath in ␣M-glc uptake experiments and found that 250 M Pz inhibited the sugar transport into oocytes (Fig. 5A ). In the absence of Pz, mouse SGLT3b-expressing oocytes transported 7.8 Ϯ 0.3 pmol (n ϭ 4) of ␣M-glc and the uptake was reduced to 1.3 Ϯ 0.1 pmol (n ϭ 4) by Pz, the same level as the control oocytes (noninjected).
In addition to blocking transport, Pz also inhibited the sugar-induced current in mSGLT3b-expressing oocytes. To measure the inhibition constant for transport, K i (11), for Pz, we measured currents induced by 60 mM ␣M-glc (equal to the K 0.5 for mSGLT3b) in the presence of Pz at concentrations ranging from 10 M to 500 M at various voltages. Figure 5B shows current induced by 60 mM ␣M-glc in the absence of Pz and in the presence of 50 M and 250 M Pz, at voltages from Ϫ150 mV to ϩ50 mV. The sugar-induced currents were reduced by about half in the presence of 50 M Pz and were reduced much more by 250 M Pz. We repeated this experiment with additional Pz concentrations (from 0 to 400 M) and to determine K i , we plotted the fraction current reduced as a function of Pz concentration at each voltage and fit the data with Eq. 1. Figure 5C displays an example of the data and fit (dashed line) for a single oocyte, showing that at Ϫ90 mV, K i was 49 Ϯ 1 M and the maximum inhibition was 92% at saturating concentrations. Figure 5D shows averaged K i data from several oocytes expressing mSGLT3b (n ϭ 3), at voltages ranging from Ϫ150 mV to Ϫ10 mV. The K i were voltage dependent, presenting lower values at more hyperpolarizing voltages.
Pre-steady-state analysis. Pre-steady-state currents are attributed to charge transfer involved in the dissociation of external Na ϩ ions and reorientation of the empty protein in the membrane (13, 19) . These currents can be recorded after a step change in membrane voltage in the absence the sugar. Figure 6 shows currents recorded from a typical mSGLT3b-expressing oocyte clamped at Ϫ50 mV and stepping the membrane potential to voltages ranging from Ϫ150 mV to ϩ50 mV for 100 ms ("On" currents) and returning the voltage to Ϫ50 mV (Off currents), in the absence of sugar (Fig. 6A) and in the presence of 150 mM ␣M-glc (Fig. 6B) . The presence of sugar increased the steady-state currents and decreased the Fig. 4 . mSGLT3b transports sugar. A: sugar transport was measured in mSGLT1 and mSGLT3b-expressing oocytes bathed in 50 M ␣M-glc. Sugar uptake was higher in mSGLT3b than in noninjected oocytes (P ϭ 0.0007, by t-test). However, the sugar uptake in mSGLT3b was about 60-fold lower than in mSGLT1-expressing oocytes. Bars show means Ϯ SE; n ϭ 3. B: charge to sugar uptake was uncoupled in mSGLT3b. Simultaneous measurement of sugar uptake and charge uptake was measured in oocytes expressing mSGLT3b, clamped at Ϫ90 mV, and perfused with 5 mM ␣M-glc. The ratio of charge to sugar uptake was 2.6 Ϯ 0.09. pre-steady-state currents, as previously observed in SGLT1 proteins (18, 19) . The charge movements measured with the On and Off voltage pulses are equal and opposite (13) . We analyzed the Off pre-steady-state currents at each voltage to obtain the charge movement, Q, by subtracting the membrane capacitance and the steady-state conductances, and then integrating the transient currents. The charge at each voltage (Q/V) was plotted (Fig. 6C) and fit with the Boltzmann equation to obtain the maximal charge transfer (Q max ), the membrane potential where there is 50% charge transfer (V 0.5 ), and the apparent valence of the movable charge (z). In the example shown in Fig. 6C , the Q max was 26 nC, V 0.5 was Ϫ16 mV, and apparent turnover was 81 cycles/s. To calculate this apparent turnover number in SGLT proteins, we divided the maximum sugar-induced current (I max ) by the Q max from the same oocyte, according to established protocols (13, 17, 18) . The averaged results of the pre-steady-state analysis from several oocytes are presented in Table 1 , illustrating that, in mSGLT3b, the Q max A: currents in one mSGLT3b-expressing oocyte clamped at Ϫ50 mV with 100-ms test pulses to voltages from Ϫ150 mV to ϩ50 mV in Na ϩ solution in the absence of sugar. Individual line on left indicates zero current. B: the same recording was repeated in the presence of 150 mM ␣M-glc. Steady-state currents were larger, and pre-steadystate currents disappeared. C: charge-voltage relationship in one mSGLT3b-expressing oocyte. The data were fit with a Boltzmann equation (Eq. 2) to obtain the parameters Qmax (maximum transient charge) V0.5 (membrane potential where there is 50% charge transfer), z (apparent valence of the movable charge), and turnover number shown in Table 1 . http://ajpcell.physiology.org/ was 25 nC, V 0.5 was Ϫ17 mV, and z was 0.7 elementary charges. Table 1 also includes the average maximal currents obtained in mSGLT3b-expressing oocytes, which was ϳ1,800 nA. For mSGLT3b, we calculated an average turnover number of 75 cycles/s. Dividing the Q max by the z, we estimate an expression level of approximately 223 ϫ 10 9 mSGLT3b proteins per oocyte. Repeating the calculation for our recent data on mSGLT1 (Q max ϭ 29 nC, z ϭ 1.0), we find approximately ϳ181 ϫ 10 9 mSGLT1 proteins per oocyte (4). Thus, our data suggest that the expression levels in oocytes of mSGLT3b and mSGLT1 are similar.
DISCUSSION
The amino acid identity between hSGLT3 and mSGLT3b is high, ϳ76%, yet between mSGLT1 and mSGLT3b, the amino acid identity is still 72%. Even though the gene that encodes this protein is classified as SGLT3b, given the high homology to both SGLT1 and human SGLT3, we felt it necessary to examine whether mSGLT3b has functional characteristics similar to SGLT1 or human SGLT3. Thus, in this study we cloned and characterized mSGLT3b to learn how the protein works at the molecular level.
Sodium and sugar binding in SGLT proteins. Our sugar specificity experiments on mSGLT3b showed that glucose, ␣M-glc, 1DO-glc, and 6DO-glc interacted with the protein and resulted in robust depolarizations. On the contrary, 2DO-glc, 3OM-glc, galactose, DNJ, or DGN did not (Fig. 1A) . Galactose interacts strongly with SGLT1 (5) but does not interact with human SGLT3 (23) or mouse SGLT3b (this work), which suggests that the axial orientation of the 4 = -OH group prevents the sugar from binding to SGLT3 proteins, likely due to steric hindrance, since the orientation of this group is the only difference between glucose and galactose.
Imino sugars like DNJ and DGN do not interact with SGLT1, but DNJ is a very strong agonist of hSGLT3, while DGN activates it more weakly (23) . Unexpectedly, we found that neither DNJ nor DGN activated mSGLT3b. Moreover, 6DO-glc, which is a substrate for hSGLT1 with an apparent affinity of 3 mM (5) and a weak agonist of hSGLT3 (23), activated mSGLT3b with an apparent affinity of ϳ6 mM (Fig.  2, B and C) . This is the strongest apparent sugar affinity we found in mSGLT3b. In fact, the apparent affinity of 6DO-glc for mSGLT3b is about four times stronger that the glucose K 0.5 , which suggests that the ϪOH group on the sixth position of the pyranose ring of glucose prevents the sugar from binding strongly to the protein and thus reduces the apparent affinity. Overall, we found that the sugar binding and selectivity of mSGLT3b had features of both hSGLT3 and SGLT1. On the basis of the differences in sugar selectivity that we observed between human and mouse SGLT3 proteins, our data suggest that studies which employ glucosides or imino sugars in rodents should exercise caution in interpreting which SGLT protein(s) they have activated and whether their results are translatable to humans.
We also determined the apparent Na ϩ affinity in mSGLT3b. To do so, we measured the sugar-induced current in solutions with different Na ϩ concentrations. We found that the K Na 0.5 was ϳ20 mM at Ϫ150 mV and that the values were higher at more depolarizing voltages. The sugar in the solution should be high enough such that it would not be limiting: we used 150 mM ␣M-glc. However, this concentration of sugar, although quite high, could not totally saturate mSGLT3b because of its low apparent affinity for sugars. We could not use a higher concentration of sugar in the experiments due to osmotic effects. Thus, the values we obtained likely represent an estimate of the apparent Na ϩ affinity due to our inability to fully saturate the sugar-binding site.
Transport and stoichiometry in mSGLT3b. Our data clearly demonstrate that unlike human SGLT3, mSGLT3b transports sugar (Fig. 4, A and B, and Fig. 5 ). However, under our experimental conditions the level of transport is less than seen in mSGLT1-expressing oocytes. What is the cause of this reduced transport? Possibilities behind this decreased transport include lower expression levels, slower protein turnover, a protein distribution that favors an inward-facing state, an uncoupled transport cycle, or finally, reduced affinity for sugar, leading to reduced substrate binding site occupancy at the concentrations used. We considered these possibilities below.
Pre-steady-state currents have been described in secondary active transporters (11, 19, 24) . Pre-steady-state currents in SGLT proteins were first described in rabbit SGLT1 (3) when the membrane potential was changed in Na ϩ . We observed pre-steady-state currents in our mSGLT3b recordings under conditions where pre-steady-state currents are not observed in hSGLT3. The analysis of these mSGLT3b currents ( Fig. 6 and Table 1 ) shows kinetics similar to mSGLT1 (4): Q max , or maximal charge transfer (which also is reflective of the expression level of the protein), is ϳ24 nC, comparable to the value obtained in mSGLT1 (4) . The apparent turnover number of mSGLT3b was 75 cycles/s, also comparable to mSGLT1. V 0.5 Comparison of a cross section of functional properties of mSGLT3b, SGLT1, and hSGLT3. Various properties show similarity to either the Na ϩ glucose transporter SGLT1 or the glucosensor hSGLT3. Notably, mSGLT3b shows a low affinity for sugar, and an uncoupled stoichiometry leading to additional current for each sugar molecule bound and transported. Reference numbers are given parentheses. DNJ, 1-deoxy-nojirimycin. Values are means Ϯ SE; n ϭ 10. Kinetics and maximal activity of mouse sodium-dependent glucose transporter type 3b (mSGLT3b). All parameters [except maximal current (Imax)] were obtained from fitting pre-steady-state current data to a Boltzmann equation as shown in Fig. 6C . Imax was derived from fits of sugar dose-response curves to Eq. 1. Qmax, maximal charge transfer; V0.5, membrane potential at which there is 50% charge transfer; z, apparent valence of the movable charge.
in mSGLT3b was Ϫ17 mV, slightly more depolarized than that obtained in mSGLT1 (Ϫ30 mV). V 0.5 is the membrane potential at which the charge is equally distributed (voltage at 50% Q max ), and thus it is representative of the potential at which the unbound protein-binding sites are equally distributed between inward-and outward-facing states. A V 0.5 of Ϫ17 mV suggests that, at a resting membrane potential, the protein will favor an outward-facing conformation. These data, obtained by the analysis of the pre-steady-state currents, indicate that the protein has similar kinetic characteristics to mSGLT1, and that expression levels, rapidity of protein turnover, and a changed outward-inward-facing protein distribution are all unlikely to contribute to the lower transport levels.
Human SGLT3 displays a behavior of totally uncoupled transport, i.e., ion flux with no sugar transport (6), while hSGLT1 is tightly coupled at 2 Na ϩ ions per sugar molecule transported (14) . An uncoupled transport in mSGLT3b could explain the robust currents seen in combination with the small amount of transported sugar. In experiments that measured sugar uptake simultaneously to charge transport, we found that with each sugar molecule, 2.6 net positive charges were transported, indicating that even though mSGLT3b transports sugar, it is not as tightly coupled as in SGLT1. However, this slight uncoupling is unlikely to contribute significantly to the lower transport levels seen in mSGLT3b.
Is then the sugar affinity responsible for the low glucose transport? The apparent glucose affinity for mSGLT3b was very low (ϳ60 mM), and for hSGLT3 it is also low [20 -60 mM (6, 23) ]. Our transport assays used 50 M of sugar to measure the levels of uptake, which is ϳ10% of the K 0.5 of mSGLT1. This concentration is, however, only 0.08% of the K 0.5 we calculated for mSGLT3b. Ignoring the partially uncoupled stoichiometry, Eq. 1 predicts that at these relative concentrations (0.08% K 0.5 vs. 10% K 0.5 ), the transport activity of mSGLT3b should be ϳ2% that of mSGLT1, which is very close to what we measured in our assay. This suggests that the lower uptake seen is mSGLT3b is due predominantly to the lower apparent affinity for sugar.
What functional features make SGLT3 a suitable sugar sensor? It has been suggested that the current induced by glucose in hSGLT3 could be a signal for the cell to detect changes in extracellular glucose concentrations (6) . Those currents are carried by the cations transported through the protein and induced by the sugar. On the basis of this simple criterion, SGLT1 could be also a sugar sensor, independently of its ability to transport sugar. However, the normal glucose concentration in blood is around 5 mM and it can increase to higher values after eating or in pathological conditions such as diabetes. Because the apparent affinity for sugar is low in mSGLT3b, just as in hSGLT3, the protein will be able to signal the change in blood glucose levels in this concentration range. On the contrary, in proteins with a high glucose affinity, like mSGLT1 [K 0.5 ϭ 0.5 mM (4)], those increases in blood glucose would not be detected because the protein would be saturated and maximally activated at all times. Studies in pig (1) and human (6) indicate that SGLT3 is expressed in intestine, kidney, and skeletal muscle, among other tissues. Nevertheless, the effects of SGLT3 on tissue physiology have not yet been fully explored.
In summary, we found that mSGLT3b has biophysical features resembling both hSGLT3 and SGLT1 (Table 2) . Mouse SGLT3b transports sugar and interacts with 6DO-glc, but not with imino sugars, characteristics that resemble SGLT1 proteins. However, it also transports sugar uncoupled to ions, does not interact with galactose, and, importantly, has low affinity for sugars, which are characteristics that resemble hSGLT3. Thus, although the features of mSGLT3b are somewhat mixed between SGLT1 and hSGLT3, the features that should make it function as a sugar sensor, namely, low sugar affinity and a slight uncoupling leading to greater current transported than sugar in each protein cycle, remain. Therefore, we conclude that mSGLT3b likely functions primarily as a sugar sensor like hSGLT3, although it is also capable of sugar transport.
